An animal model for anaplastic large cell lymphoma in the immunocompetent syngeneic C57BI/6 mouse

被引:9
作者
Bittner, C
Feller, AC
Renauld, JC
Lange, K
Pietrzik, R
Jenetzky, C
Briese, J
Gaiser, T
Müller, A
Wiedemann, GJ
Van Snick, J
Merz, H
机构
[1] Med Univ Lubeck, Dept Pathol, D-23538 Lubeck, Germany
[2] Med Univ Lubeck, Dept Internal Med, D-23538 Lubeck, Germany
[3] Ludwig Inst Canc Res, Brussels Branch, Brussels, Belgium
关键词
D O I
10.1038/labinvest.3780162
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
We report on the analysis of a murine anaplastic lymphoid cell line TS1G6, established recently by interleukin (IL)-9 transfection. TS1G6 revealed a highly characteristic pattern of large anaplastic cells with mononuclear, binuclear, or multinuclear cells resembling Hodgkin (H) or Sternberg-Reed (SR) cells. This cell line is tumorigenous after injection of as few as 10(4) lymphoma cells into nude or immunocompetent C57Bl/6 mice and leads to death from progressive disease of all treated animals within a few weeks. The histological analysis of these tumors revealed a diffuse large cell malignant lymphoma that is morphologically almost identical to human anaplastic large cell lymphoma (ALCL). The lymphoma cells did not show overexpression of the anaplastic lymphoma kinase (ALK) gene, which is found in about 50% of the cases of human ALCL. Thus, this model may be an animal model for an important subset of human ALCL. The cytokine profile, which is of the T helper 2 type, showed strong parallels to the human lymphoma counterpart. Mice suffering from such lymphomas could not be cured with a regimen using high dose cyclophosphamide similar to many ALCL patients. Such an animal model for ALCL has not yet been recognized, but may provide the basis for investigating new antitumor immunotherapies in a fully immunocompetent host.
引用
收藏
页码:1523 / 1531
页数:9
相关论文
共 30 条
[1]  
AUSUBEL I, 1999, CURRENT PROTOCOLS MO, V1
[2]   DEL CELL-LINE - A MALIGNANT HISTIOCYTOSIS CD30 + T(5-6)(Q35-P21) CELL-LINE [J].
BARBEY, S ;
GOGUSEV, J ;
MOULY, H ;
LEPELLETIER, O ;
SMITH, W ;
RICHARD, S ;
SOULIE, J ;
NEZELOF, C .
INTERNATIONAL JOURNAL OF CANCER, 1990, 45 (03) :546-553
[3]   Human interleukin-10 expression in T natural killer-cell lymphomas -: Association with anaplastic large cell lymphomas and nasal natural killer-cell lymphomas [J].
Boulland, ML ;
Meignin, V ;
Leroy-Viard, K ;
Copie-Bergman, C ;
Brière, J ;
Touitou, R ;
Kanavaros, P ;
Gaulard, P .
AMERICAN JOURNAL OF PATHOLOGY, 1998, 153 (04) :1229-1237
[4]   SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION [J].
CHOMCZYNSKI, P ;
SACCHI, N .
ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) :156-159
[5]   CD30-MEDIATED SIGNALING PROMOTES THE DEVELOPMENT OF HUMAN T-HELPER TYPE 2-LIKE T-CELLS [J].
DELPRETE, G ;
DECARLI, M ;
DELIOS, MM ;
DANIEL, KC ;
ALMERIGOGNA, F ;
ALDERSON, M ;
SMITH, CA ;
THOMAS, E ;
ROMAGNANI, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (06) :1655-1661
[6]   TRANSPLANTATION OF NORMAL AND LEUKEMIC HUMAN BONE-MARROW INTO IMMUNE-DEFICIENT MICE - DEVELOPMENT OF ANIMAL-MODELS FOR HUMAN HEMATOPOIESIS [J].
DICK, JE ;
LAPIDOT, T ;
PFLUMIO, F .
IMMUNOLOGICAL REVIEWS, 1991, 124 :25-43
[7]  
Dirks WG, 1996, LEUKEMIA, V10, P142
[8]  
Drexler H G, 1992, Hum Cell, V5, P42
[9]   RECENT RESULTS ON THE BIOLOGY OF HODGKIN AND REED-STERNBERG CELLS .2. CONTINUOUS CELL-LINES [J].
DREXLER, HG .
LEUKEMIA & LYMPHOMA, 1993, 9 (1-2) :1-25
[10]  
Falini B, 1999, BLOOD, V93, P2697